Allison Gordon

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Management of immune-related cutaneous adverse events with dupilumab”.

Management of immune-related cutaneous adverse events with dupilumab

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007324

N/A

0.598DataRank · unranked

53 citations

Stephanie Gu, Joseph R. Stoll, Andrea P. Moy, Stephen W. Dusza, Allison Gordon +8 more

Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor–positive breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12100

N/A

0.165DataRank · unranked

2 citations

Alexander Pan, George Dranitsaris, Ucalene Harris, Sarat Chandarlapaty, Chau T. Dang +11 more

Dupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series

The Oncologist(2025)10.1093/oncolo/oyaf208

N/A

0DataRank · unranked

12 citations

Andrea P. Moy, Stephen W. Dusza, Alison J. Moskowitz, Gopa Iyer, Afsheen N. Iqbal +8 more

No serum estradiol changes with 5-alpha reductase inhibitors for late alopecia in cancer survivors: A retrospective cohort study

Journal of the American Academy of Dermatology(2025)10.1016/j.jaad.2025.11.076

N/A

0DataRank · unranked

0 citations

Lavanya Mittal, Mario E. Lacouture, Stephen W. Dusza, Allison Gordon, Jacqueline Bromberg +5 more